SHANGHAI, 1er juin 2026 /PRNewswire/ -- Moyom Biotechnology a annoncé que son produit haut de gamme dédié à l'esthétique régénérative, Aphranel® MagiCCrystal CaHA Filler, a officiellement obtenu la certification au titre du règlement de l'Union européenne sur les dispositifs médicaux (EU...
Hence then, the article about aphranel magiccrystal caha filler obtient la certification mdr de l ue en tant qu injectable regenerateur de premiere qualite was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Aphranel® MagiCCrystal CaHA Filler obtient la certification MDR de l'UE en tant qu'injectable régénérateur de première qualité )
Also on site :
- JCPenney’s ‘Delicate’ Pink Sapphire Pendant Necklace Is a ‘Beautiful’ Holiday Gift, Now 79% Off
- Singapore Court grants enforcement orders authorising the seizure and sale of Tata Power's shares in Singapore companies
- Southeast Asia shouldn’t copy the U.S. healthcare model, says Walgreens Boots Alliance’s APAC head: ‘It saves your life, but it’s not very healthy’